We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Verisk Analytics
VRSK
$23.4B
| $23.9M | 0.09% |
86,855
+5,822
| +7% | +$1.62M |
|
202
Standex International
SXI
$4.03B
| $23.9M | 0.09% |
127,900
+200
| +0.2% | +$38.6K |
|
|
NOVA
203
DELISTED
Sunnova Energy
NOVA
| $23.6M | 0.09% |
6,881,651
-417,794
| -6% | -$2.09M |
|
204
Monster Beverage
MNST
$91.4B
| $23.4M | 0.09% |
890,942
+364,442
| +69% | +$9.66M |
|
205
Elevance Health
ELV
$86.9B
| $23.4M | 0.09% |
63,456
-11,864
| -16% | -$4.96M |
|
206
APi Group
APG
$18.7B
| $23.1M | 0.09% |
964,950
+885,000
| +1,107% | +$21M |
|
207
lululemon athletica
LULU
$13.6B
| $23M | 0.09% |
60,184
-8,767
| -13% | -$2.86M |
|
208
Freeport-McMoran
FCX
$95.8B
| $23M | 0.09% |
603,398
-71,595
| -11% | -$3.2M |
|
209
Chipotle Mexican Grill
CMG
$41.5B
| $22.6M | 0.09% |
375,196
-118,457
| -24% | -$7.14M |
|
210
Hilton Worldwide
HLT
$72.5B
| $22.6M | 0.09% |
91,350
+8,449
| +10% | +$2.07M |
|
211
Sysco
SYY
$40.4B
| $22.6M | 0.09% |
295,180
+9,485
| +3% | +$726K |
|
212
Hubbell
HUBB
$26.8B
| $22.6M | 0.09% |
53,858
+15,719
| +41% | +$7.02M |
|
213
Church & Dwight Co
CHD
$24B
| $22.4M | 0.09% |
214,250
-46,519
| -18% | -$4.91M |
|
214
Fortinet
FTNT
$119B
| $22.4M | 0.09% |
237,404
+41,609
| +21% | +$3.7M |
|
|
215
Rockwell Automation
ROK
$49.6B
| $22.4M | 0.09% |
78,359
-141,808
| -64% | -$39.9M |
|
216
General Mills
GIS
$20.6B
| $22.3M | 0.09% |
350,438
+55,268
| +19% | +$3.71M |
|
|
AXON
217
Axon Enterprise
AXON
$48.2B
| $22.2M | 0.08% |
37,302
-6,000
| -14% | -$3.26M |
|
218
Cigna
CI
$73.6B
| $22.1M | 0.08% |
80,145
+2,923
| +4% | +$932K |
|
219
Iron Mountain
IRM
$37.3B
| $22.1M | 0.08% |
209,970
+2,425
| +1% | +$285K |
|
220
JD.com
JD
$39.3B
| $22.1M | 0.08% |
636,507
-60,000
| -9% | -$2.32M |
|
221
Corteva
CTVA
$50.4B
| $22M | 0.08% |
386,028
+91,163
| +31% | +$5.39M |
|
222
Air Products & Chemicals
APD
$68B
| $21.9M | 0.08% |
75,363
-5,569
| -7% | -$1.75M |
|
223
Align Technology
ALGN
$12.4B
| $21.6M | 0.08% |
103,592
-5,280
| -5% | -$1.18M |
|
224
Crown Castle
CCI
$31.9B
| $21.4M | 0.08% |
236,300
+17,427
| +8% | +$1.82M |
|
225
Aon
AON
$74.5B
| $21.3M | 0.08% |
59,338
+4,860
| +9% | +$1.79M |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.